In 40 seconds
Aphasia (language loss) affects around one-third of stroke survivors. rTMS for aphasia has one of the cleanest targets in stroke neuromodulation — 1 Hz to the right (contralesional) Broca's-homologue area to release the lesioned left language cortex from transcallosal inhibition. The Naeser lineage of trials (2005 onwards) established this protocol. Xu 2025 network meta-analysis confirms 1 Hz right inferior frontal as the most effective approach. UK speech & language therapy (SALT) remains the NICE-recommended first-line — rTMS sits as research adjunct. No NHS commissioning. UK access via trial or private clinic.
Quick facts
- Aphasia prevalence: ~33% of stroke survivors
- Best-supported target: 1 Hz right Broca's homologue (Naeser lineage)
- Xu 2025 network meta: LF contralesional Broca's homologue most effective
- Mechanism: Reduces transcallosal inhibition of lesioned left language cortex
- First-line UK: Speech & language therapy (SALT) — NICE NG236
- UK rTMS access: Research trial or private clinic
The cleanest target in stroke rTMS
Post-stroke aphasia is one of the few stroke domains where rTMS has a clean, well-supported cortical target. The Naeser lineage of trials (Margaret Naeser, Boston VA, from 2005) established that 1 Hz stimulation over the right (contralesional) pars triangularis of inferior frontal gyrus — Broca's homologue — improves naming and language function in non-fluent aphasia. The mechanism: the right Broca's-homologue area becomes over-active after left-hemisphere language stroke and inhibits residual left-hemisphere function via transcallosal pathways. Suppressing it with 1 Hz rTMS releases left-side recovery.
Xu 2025 network meta-analysis pooled aphasia rTMS protocols and confirmed 1 Hz over right inferior frontal gyrus as the most effective approach. Effects on naming are most consistent; effects on auditory comprehension are less consistent.
UK first-line for post-stroke aphasia per NICE NG236 is speech & language therapy (SALT) — early, intensive, individualised. rTMS sits as research adjunct. The Centre for Better Communication (UCL) and major UK aphasia research centres recruit periodically.
Frequently asked questions
Can rTMS help my speech after stroke?
1 Hz to right Broca's homologue has consistent published signal in non-fluent aphasia. Xu 2025 network meta confirms. UK access via trial.
Is this on the NHS?
No. NHS commissions SALT for post-stroke aphasia — NICE NG236 recommendation. rTMS is not routinely commissioned.
What is Broca's homologue?
The right-side mirror of the left-side Broca's area (which controls speech production). After left-hemisphere stroke this becomes over-active and inhibits residual left function.
Will rTMS replace speech therapy?
No. The published trials combine rTMS with SALT. rTMS is an adjunct, not a substitute.
Does rTMS help comprehension or only speech production?
Effects are most consistent on naming and language production. Comprehension effects are less consistent.
Can chronic aphasia respond?
Yes — Naeser trials and others have shown effects in chronic aphasia. Magnitude is generally smaller than subacute phase.
Should I try a PEMF mat for aphasia?
No completed RCT supports this. Mechanism is fundamentally different from clinical rTMS.
How do I find a UK aphasia rTMS trial?
ClinicalTrials.gov is the registry. UCL Centre for Better Communication, Sheffield, Edinburgh and Cambridge are active recruiters.
Related pages
Looking for a PEMF clinic in the UK?
We list every credible PEMF therapy provider in the UK. No UK clinic can legally claim to treat stroke with PEMF or rTMS.